Chargement en cours...
Potential for Therapeutic Benefit among Cystic Fibrosis Populations Excluded from Clinical Trials or Labeling of Marketed Therapies
Remarkable advances in the management of individuals born with cystic fibrosis (CF) would not have been realized without empiric trial and error by CF clinicians with treatments developed and available for other purposes. As the testing and registration of CF-specific treatments have increased, so t...
Enregistré dans:
| Publié dans: | Ann Am Thorac Soc |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
American Thoracic Society
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5466179/ https://ncbi.nlm.nih.gov/pubmed/27518252 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1513/AnnalsATS.201606-462PS |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|